Abstract: A liquid crystal panel and a manufacture method thereof, a liquid crystal display device are disclosed. The manufacture method of a liquid crystal panel includes: providing a first substrate, a second substrate and a liquid crystal layer between the first substrate and the second substrate, wherein the liquid crystal layer includes a liquid crystal material and photopolymerizable monomers; and exposing the liquid crystal layer to allow the photopolymerizable monomers to be polymerized at a position of exposing to form a columnar spacer.

Abstract: The present application discloses a display substrate. The display substrate includes a base substrate; a color filter on the base substrate and including a plurality of color filter blocks; and an actuator configured to actuate each of the plurality of color filter blocks thereby controlling a wavelength of light transmitted through each of the plurality of color filter blocks.

Abstract: A display panel and a display device are provided. The display panel includes a display liquid crystal panel and a light control panel that are stacked; the display liquid crystal panel includes grid lines; the grid lines include first grid lines extending along a first direction and second grid lines extending along a second direction, the first direction intersect with the second direction; the first grid lines and the second grid lines define a plurality of sub-pixel units; the light control panel allows backlight to illuminate into the display liquid crystal panel through the light control panel, and includes signal lines; the signal lines include first signal lines extending along the first direction and second signal lines extending along the second direction; the first signal lines and the second signal lines define a plurality of light control units; at least part of the signal lines is a fold line.

Abstract: The present invention provides a PEG-ACS/M-siRNA nanocomposite application, and method for reducing the histamine content during fishmeal storage thereof. A small interfering ribonucleic acid (siRNA) is designed and prepared according to a histidine decarboxylase gene of Morganella morganii (Morganella morganii subsp. morganii KT), and the histidine decarboxylase gene has a sequence of SEQ ID No: 1. A PEG-ACS/M-siRNA nanocomposite is prepared by using a PEGylated arginine-modified chitosan as a carrier. A PEG-ACS/M-siRNA nanocomposite is added to fishmeal in a certain ratio. The method for reducing the histamine content during fishmeal storage has a significant inhibitory effect on the histamine content during fishmeal storage, and can reduce the histamine content in fishmeal by 49%-53%, which has great significance for the control of biogenic amines in fishmeal in the feed industry.

Abstract: Provided is a nucleic acid molecule of a codon optimized precursor gene and signal peptide gene of a human insulin analogue. The nucleic acid molecule comprises a nucleic acid molecule encoding the precursor of the fusion insulin analogue and a nucleic acid molecule encoding the yeast secreting signal peptide ?-factor. The nucleic acid molecule improves the expression of the precursor of the insulin analogue in Pichia Pastoris, and reduces the production cost of the human insulin analogue.

Abstract: A horizontal electric field type display panel, a method of manufacturing the same, and a display device are provided in embodiments of the disclosure, the horizontal electric field type display panel including: a first substrate and a second substrate arranged opposite to each other; a liquid crystal layer between the first substrate and the second substrate; and a first compensation film layer between the first substrate and the second substrate, wherein the first compensation film layer is configured to compensate for a phase delay of an axial light in a condition that the display panel is subjected to a non-uniform external force.

Abstract: A current interrupt apparatus and a flipping member thereof, a battery cover plate assembly, a cell, a battery module, a power battery, and an electric vehicle are provided. The flipping member is to be electrically connected to a score member, and can act under an effect of air pressure to break a score on the score member so as to cut off the electrical connection to the score member. A first connection region to be electrically connected to the score member and a second connection region to be electrically connected to an outer electrode terminal of a battery are formed on the flipping member. A deformation cushion region is further formed on the flipping member. The deformation cushion region is disposed between the first connection region and the second connection region and around the first connection region.

Abstract: Provided is an acylated derivative of human insulin or an analogue thereof. Specifically disclosed is an acylated derivative of a human insulin analogue, or zinc complex thereof; the human insulin analogue being derivatized is preferably Des(B30) human insulin; the acylated derivative is longer-lasting than existing insulin analogues and acylated derivatives thereof, its blood glucose reduction is more steady, and it is more stable in storage.

Abstract: A battery cover plate assembly, a cell, battery module, a power battery, and an electric vehicle are provided. The battery cover plate assembly includes a cover plate, an inner electrode terminal, and an outer electrode terminal. The inner electrode terminal and the outer electrode terminal are electrically connected by using a current interrupt device. The current interrupt device includes a score member and a flipping member. The flipping member is electrically connected to the score member. In addition, the flipping member can act under an effect of air pressure to break a score on the score member. The flipping member forms an elongated structure extending along the cover plate.

Abstract: A display panel and a display device are provided. The display panel includes a display liquid crystal panel and a light control panel that are stacked; the display liquid crystal panel includes grid lines; the grid lines include first grid lines extending along a first direction and second grid lines extending along a second direction, the first direction intersect with the second direction; the first grid lines and the second grid lines define a plurality of sub-pixel units; the light control panel allows backlight to illuminate into the display liquid crystal panel through the light control panel, and includes signal lines; the signal lines include first signal lines extending along the first direction and second signal lines extending along the second direction; the first signal lines and the second signal lines define a plurality of light control units; at least part of the signal lines is a fold line.

Abstract: A backlight driving circuit includes a backlight driving sub-circuit. The backlight driving sub-circuit includes at least one voltage receiving end; at least two switch sub-circuits and at least two driving ends. The voltage receiving end is connected to first electrodes of at least two light emitting elements. Second electrodes of the at least two light emitting elements are connected to first ends of the at least two switch sub-circuits, respectively. The control end of each switch sub-circuit receives a switch control signal. The second end of each switch sub-circuit is connected to a corresponding driving end. The first end and the second end of the switch sub-circuit are connected or disconnected under the control of the switch control signal.

Abstract: Embodiments of the present disclosure provide a pixel circuit. The pixel circuit includes a first transistor and a photosensitive component. A first end and a second end of the photosensitive component are connected to a gate line and a pixel electrode, respectively, and the photosensitive component is configured to transmit a signal of the gate line to the pixel electrode in response to receiving an external light signal. Embodiments of the present disclosure further provide a pixel unit including the pixel circuit as well as a display panel.

Abstract: A magnesium battery electrolyte with a wide electrochemical window was developed. The electrolyte includes an organic boron magnesium salt and an aprotic polar solvent. The organic boron magnesium salt is an organic boron magnesium salt complex formed by compounding a Lewis acid with a boron center and a magnesium-containing Lewis base R?2-nMgXn, wherein n is 0 or 1, R and R? respectively represent a fluoroaryl group, an alkylated aryl group, an aryl group, an alkyl group, or a pyrrolidinyl group, and X represents a halogen. The solvent is an aprotic polar solvent such as ether or a mixed solvent thereof. The concentration of the electrolyte is 0.25 to 1 mol/L, and the electric conductivity is 0.5 to 10 mS/cm. The electrolyte allows reversible deposition/dissolution of magnesium, features good cycling stability, and has a wide electrochemical window (>3.0V vs. Mg/Mg2+).

Abstract: An encapsulation structure, a manufacturing method thereof and a display apparatus are provided in the field of display device encapsulation. The encapsulation structure includes a plurality of film layers coated on the outside of a display device and the plurality of film layers include an inorganic layer and an organic layer that are laminated. The organic layer includes a polymer matrix and a repairing microstructure.

Abstract: The present invention provides a PEG-ACS/M-siRNA nanocomposite application, and method for reducing the histamine content during fishmeal storage thereof. A small interfering ribonucleic acid (siRNA) is designed and prepared according to a histidine decarboxylase gene of Morganella morganii (Morganella morganii subsp. morganii KT), and the histidine decarboxylase gene has a sequence of SEQ ID No: 1. A PEG-ACS/M-siRNA nanocomposite is prepared by using a PEGylated arginine-modified chitosan as a carrier. A PEG-ACS/M-siRNA nanocomposite is added to fishmeal in a certain ratio. The method for reducing the histamine content during fishmeal storage has a significant inhibitory effect on the histamine content during fishmeal storage, and can reduce the histamine content in fishmeal by 49%-53%, which has great significance for the control of biogenic amines in fishmeal in the feed industry.

Abstract: A backlight driving circuit includes a backlight driving sub-circuit. The backlight driving sub-circuit includes at least one voltage receiving end; at least two switch sub-circuits and at least two driving ends. The voltage receiving end is connected to first electrodes of at least two light emitting elements. Second electrodes of the at least two light emitting elements are connected to first ends of the at least two switch sub-circuits, respectively. The control end of each switch sub-circuit receives a switch control signal. The second end of each switch sub-circuit is connected to a corresponding driving end. The first end and the second end of the switch sub-circuit are connected or disconnected under the control of the switch control signal.

Abstract: Provided is an acylated derivative of human insulin or an analogue thereof. Specifically disclosed is an acylated derivative of a human insulin analogue, or zinc complex thereof; said acylated derivative is longer-lasting than existing insulin analogues and acylated derivatives thereof, its blood glucose reduction is more steady, and it is more stable in storage.

Abstract: A screenshot method and screenshot apparatus for an electronic terminal are provided. The screenshot method for an electronic terminal includes receiving a biometric feature signal, sensing a sliding track formed by a sliding operation on a display area of the electronic terminal during a period when the biometric feature signal is inputted, and intercepting an image surrounded by the sliding track. With the above screenshot method and apparatus for an electronic terminal, screenshots can be performed quickly, based on the combination of a biometric feature and the sliding operation, and thus the experience of user can be improved.